Drug Information

Drug General Information
Drug ID
D0Y4SO
Former ID
DNC014324
Drug Name
9-[9-(beta-Carboline-9-yl)nonyl]-beta-carboline
Drug Type
Small molecular drug
Indication Discovery agent Investigative [530824]
Structure
Download
2D MOL

3D MOL
Formula
C31H32N4
Canonical SMILES
C1=CC=C2C(=C1)C3=C(N2CCCCCCCCCN4C5=CC=CC=C5C6=C4C=NC=C6<br />)C=NC=C3
InChI
1S/C31H32N4/c1(2-4-10-20-34-28-14-8-6-12-24(28)26-16-18-32-22-30(26)34)3-5-11-21-35-29-15-9-7-13-25(29)27-17-19-33-23-31(27)35/h6-9,12-19,22-23H,1-5,10-11,20-21H2
InChIKey
JJAATQLWMKLMJU-UHFFFAOYSA-N
PubChem Compound ID
46223113
Target and Pathway
Target(s) Cholinesterase Target Info Inhibitor [530824]
PANTHER Pathway Muscarinic acetylcholine receptor 1 and 3 signaling pathway
Muscarinic acetylcholine receptor 2 and 4 signaling pathway
Nicotinic acetylcholine receptor signaling pathway
WikiPathways Irinotecan Pathway
References
Ref 530824J Med Chem. 2010 May 13;53(9):3611-7.Bivalent beta-carbolines as potential multitarget anti-Alzheimer agents.
Ref 530824J Med Chem. 2010 May 13;53(9):3611-7.Bivalent beta-carbolines as potential multitarget anti-Alzheimer agents.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.